Amit Hasija
Direttore Finanziario/CFO presso MILESTONE PHARMACEUTICALS INC.
Patrimonio netto: 30 342 $ in data 30/04/2024
Posizioni attive di Amit Hasija
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Direttore Finanziario/CFO | 09/09/2019 | - |
Milestone Pharmaceuticals USA, Inc.
 Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Treasurer | - | - |
Storia della carriera di Amit Hasija
Precedenti posizioni note di Amit Hasija
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/03/2017 | 01/01/2019 |
| SANOFI | Corporate Officer/Principal | 01/10/2012 | 01/01/2017 |
| MERCK & CO., INC. | Direttore operativo | 01/01/1995 | 01/01/2000 |
Formazione di Amit Hasija
| Drexel University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Francia | 2 |
| Canada | 2 |
Posizioni
| Director of Finance/CFO | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SANOFI | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Health Technology |
- Borsa valori
- Insiders
- Amit Hasija
- Esperienza